Jianfei Tu

2.4k total citations · 1 hit paper
90 papers, 1.7k citations indexed

About

Jianfei Tu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jianfei Tu has authored 90 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 28 papers in Pulmonary and Respiratory Medicine and 23 papers in Surgery. Recurrent topics in Jianfei Tu's work include Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Cancer Mechanisms and Therapy (10 papers). Jianfei Tu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (21 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Cancer Mechanisms and Therapy (10 papers). Jianfei Tu collaborates with scholars based in China, United States and Czechia. Jianfei Tu's co-authors include Zhongwei Zhao, Jiansong Ji, Jiansong Ji, Fazong Wu, Minjiang Chen, Qiaoyou Weng, Jingjing Song, Xihui Ying, Dengke Zhang and Shiji Fang and has published in prestigious journals such as Journal of Clinical Oncology, ACS Nano and Hepatology.

In The Last Decade

Jianfei Tu

85 papers receiving 1.7k citations

Hit Papers

Cuproptosis, ferroptosis and PANoptosis in tumor immune m... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope
    2024 53 citations Bufu Tang, Qiaoyou Weng et al. profile →

Peers

Jianfei Tu
Wenjing Yu China
Xin Lu China
Yu‐Ming Wang Taiwan
Di Lu China
Yiyao Xu China
Lu Cao China
Zhiying Yang China
Jun Yan China
Jan‐Show Chu Taiwan
Yi Gao China
Wenjing Yu China
Jianfei Tu
Citations per year, relative to Jianfei Tu Jianfei Tu (= 1×) peers Wenjing Yu

Countries citing papers authored by Jianfei Tu

Since Specialization
Citations

This map shows the geographic impact of Jianfei Tu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianfei Tu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianfei Tu more than expected).

Fields of papers citing papers by Jianfei Tu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jianfei Tu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianfei Tu. The network helps show where Jianfei Tu may publish in the future.

Co-authorship network of co-authors of Jianfei Tu

This figure shows the co-authorship network connecting the top 25 collaborators of Jianfei Tu. A scholar is included among the top collaborators of Jianfei Tu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jianfei Tu. Jianfei Tu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tu, Jianfei, et al.. (2025). Bronchial artery embolization for hemoptysis: a consensus statement by the Chinese College of Interventionalists. World Journal of Emergency Medicine. 16(3). 197–197. 1 indexed citations
2.
Wei, Ran, Mengxuan Zuo, Wang Li, et al.. (2025). Using Machine Learning to Predict Advanced-Stage Progression of Intermediate-Stage Hepatocellular Carcinoma after Transarterial Chemoembolization. Radiology Imaging Cancer. 7(5). e250034–e250034.
3.
4.
Song, Kangkang, et al.. (2024). Patch Matching for Few-Shot Industrial Defect Detection. IEEE Transactions on Instrumentation and Measurement. 73. 1–11. 5 indexed citations
5.
6.
Li, Yanyan, et al.. (2024). Improving the Electrochemical Performance of Ni-Rich LiNi0.8Co0.1Mn0.1O2 Cathodes by Suitable Sintering Temperature. ACS Applied Energy Materials. 7(24). 11827–11833. 1 indexed citations
7.
Qin, Zhenzhen, et al.. (2024). The performance analysis of supercapacitors utilizing chemically activated carbon derived from Chinese medicine residues. Biomass Conversion and Biorefinery. 15(9). 13783–13796. 4 indexed citations
8.
Tu, Jianfei, Weiyue Chen, Chunli Kong, et al.. (2024). Dual-energy computed tomography for predicting cervical lymph node metastasis in laryngeal squamous cell carcinoma. Heliyon. 10(16). e35528–e35528. 1 indexed citations
9.
Tu, Jianfei, Qing Liu, Zhuojun Meng, et al.. (2023). Recombinant supercharged polypeptides for safe and efficient heparin neutralization. Biomaterials Science. 11(16). 5533–5539. 5 indexed citations
10.
Zhang, Nannan, Gaofeng Shu, Enqi Qiao, et al.. (2022). DNA-Functionalized Liposomes In Vivo Fusion for NIR-II/MRI Guided Pretargeted Ferroptosis Therapy of Metastatic Breast Cancer. ACS Applied Materials & Interfaces. 14(18). 20603–20615. 17 indexed citations
11.
Liu, Wei‐Wen, et al.. (2022). Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort. BMJ Open. 12(4). e049789–e049789. 4 indexed citations
12.
Tu, Jianfei, Fazong Wu, Li Chen, et al.. (2021). Long Non-Coding RNA PCAT6 Induces M2 Polarization of Macrophages in Cholangiocarcinoma via Modulating miR-326 and RhoA-ROCK Signaling Pathway. Frontiers in Oncology. 10. 680500–680500. 34 indexed citations
13.
Zhu, Jinyu, Bufu Tang, Yang Gao, et al.. (2021). Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2. Journal of Inflammation Research. Volume 14. 4089–4109. 15 indexed citations
14.
Kong, Chunli, Zhongwei Zhao, Weiyue Chen, et al.. (2021). Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. European Radiology. 31(10). 7500–7511. 97 indexed citations
15.
Fang, Shiji, Jinyu Zhu, Liyun Zheng, et al.. (2021). A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation. Frontiers in Molecular Biosciences. 8. 662366–662366. 11 indexed citations
16.
Weng, Qiaoyou, Hailin Wang, Jiansheng Huang, et al.. (2021). Radiomic Feature-Based Nomogram: A Novel Technique to Predict EGFR-Activating Mutations for EGFR Tyrosin Kinase Inhibitor Therapy. Frontiers in Oncology. 11. 590937–590937. 13 indexed citations
17.
Fan, Xiaoxi, Zhongwei Zhao, Jingjing Song, et al.. (2021). LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A. Cancer Cell International. 21(1). 150–150. 9 indexed citations
18.
Zhao, Zhongwei, Jingjing Song, Dengke Zhang, et al.. (2020). Oxysophocarpine suppresses FGFR1-overexpressed hepatocellular carcinoma growth and sensitizes the therapeutic effect of lenvatinib. Life Sciences. 264. 118642–118642. 32 indexed citations
19.
Wang, Hailin, Qiaoyou Weng, Shiji Fang, et al.. (2019). Value of TSCT Features for Differentiating Preinvasive and Minimally Invasive Adenocarcinoma From Invasive Adenocarcinoma Presenting as Subsolid Nodules Smaller Than 3 cm. Academic Radiology. 27(3). 395–403. 6 indexed citations
20.
Tu, Jianfei, et al.. (2018). NEAT1 upregulates TGF‐β1 to induce hepatocellular carcinoma progression by sponging hsa‐mir‐139‐5p. Journal of Cellular Physiology. 233(11). 8578–8587. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wenjing Yu Breakdown of academic impact, for papers by Xin Lu Breakdown of academic impact, for papers by Yu‐Ming Wang Breakdown of academic impact, for papers by Di Lu Breakdown of academic impact, for papers by Yiyao Xu Breakdown of academic impact, for papers by Lu Cao Breakdown of academic impact, for papers by Zhiying Yang Breakdown of academic impact, for papers by Jun Yan Breakdown of academic impact, for papers by Jan‐Show Chu Breakdown of academic impact, for papers by Yi Gao
Rankless by CCL
2026